Open access peer-reviewed chapter - ONLINE FIRST

Resveratrol: Apromising Antiaging Agent for Cosmetic Skin Treatments

Written By

Javier Fidalgo, Ana Novo Barros and Ana Casas

Submitted: 02 August 2022 Reviewed: 05 September 2022 Published: 13 October 2022

DOI: 10.5772/intechopen.107860

Resveratrol - Recent Advances, Application, and Therapeutic Potential IntechOpen
Resveratrol - Recent Advances, Application, and Therapeutic Poten... Edited by Ali Imran

From the Edited Volume

Resveratrol - Recent Advances, Application, and Therapeutic Potential [Working Title]

Dr. Ali Imran and Dr. Hafiz Ansar Suleria

Chapter metrics overview

158 Chapter Downloads

View Full Metrics

Abstract

Nowadays, resveratrol, a polyphenolic phytoalexin is increasingly included in the formulas of cosmetic products and dermatology as an active ingredient, as a consequence of the well-known health beneficial properties, namely antioxidant, anti-inflammatory, anti-viral and anti-bacterial effects. This important compound can be biosynthesized naturally by plants or by industrial synthetic processes. Apart from its anti-inflammatory and antioxidant effects, a broad spectrum of effects has been attributed to the use of this compound such as anti-aging, skin-whitening, anti-angiogenic, collagen I and III stimulation (in fibroblasts) and estrogen-like effects, as well as the ability to protect cells against hydrogen peroxide-induced oxidative stress and UV-irradiation-mediated cell death. In cosmetology and dermatology has been popular because of its ability to penetrate the skin barrier and its anti-aging activity. In fact, resveratrol as an important impact on the regulation of inflammation and, as consequence, repair-related processes in skin. Furthermore, when administered either topically or orally has been proven to be safe and also to overcome the skin barrier. This review will focus in its potential application on melasma treatment and in photo-aging. Resveratrol chemistry, pharmacology, mechanism of action and evidence of its efficacy as photo skin aging protector and its potential use in melasma is discussed.

Keywords

  • resveratrol
  • cosmetic
  • antiaging
  • skin treatments
  • biological properties

1. Introduction

1.1 Chemistry and biological properties

Resveratrol (3,4′,5-trihydroxy-trans-stilbene) is a naturally occurring compound, belongs to the stilbenoid group of polyphenols, which is synthesized by plants (e.g., red grapes and berries). It can also be obtained by chemical synthesis, biotechnological synthesis or by plant extraction [1]. As observed in Figure 1, resveratrol consists in two phenol rings linked by an ethylene bridge, giving rise to two geometric isomers, is the biologically active trans-isomer and an inactive cis-isomer [2]. The trans-resveratrol can undergo photoisomerization (exposed to sun light or to artificial or natural UV radiation) to be converted into its biologically inactive cis-isomer [3, 4, 5].

Figure 1.

Chemical structures of resveratrol and its two isomers, trans- and cis-resveratrol. Highlighted in red circles the hydroxyl groups of the phenolic moieties of resveratrol. Highlighted in a brown squared the biologically active trans-isomer.

Resveratrol is a compound that presents several important biological properties, Figure 2.

Figure 2.

Biological properties from resveratrol.

The aim of this study is to show the efficacy and tolerability of resveratrol, that can have a topical application to the face and to determine whether this topical treatment with resveratrol can reduce anti-aging effects by improving skin barrier, and elasticity. In fact, Andrzej et al., 2022 [6] concluded that “resveratrol shows an excellent biocompatibility” representing an interesting and promissing novel therapeutical compound for the cosmetic industry.

Advertisement

2. Pharmacology, toxicity and skin permeation

Orally, and considering its structure, resveratrol is rapidly absorbed from the gastrointestinal tract, but with a low bioavailability because is rapidly metabolized in the liver [2]. In human, its plasma half-life has been reported to be 9.2 ± 0.6 hours [7], resulting not carcinogenic in mouse, without developmental and reproductive toxicity [8]. Another important characteristic from this compound, is that, as already proved, it is non-irritating to skin and eyes and non-sensitizing. In vitro and in vivo resveratrol demonstrated to be nontoxic, safe for oral and dermal application, as well as being well tolerated [9, 10, 11]. Resveratrol also showed high permeability in the skin, overcoming the skin barrier in its neutral (non-ionized) form, showing that it is readily available in the stratum corneum (SC) in animal and human studies [12, 13]. This is of high importance, once the most exposure to reactive oxygen species (ROS) takes place in the SC, supporting the use of resveratrol in cosmeceuticals [14, 15].

2.1 Possible skin application in melasma and it use in skin photoaging

2.1.1 Antioxidant activity

Skin care formulations are usually based on exogenous antioxidants that cannot be synthesized by our body, like vitamins or phenolic compounds. Some studies referred in Literature, report that resveratrol is able to inhibit UV-induced lipid peroxidation. UV irradiation (UV A and B) and blue light are known to induce the formation of free radicals, reactive oxygen species (ROS; e.g., peroxides, superoxide, hydroxyl radical) in vivo [16, 17, 18], and these reactive oxygen species may be toxic and mutagenic. They can also negatively influence some immunological processes and aging, as well as pathophysiological mechanisms leading to skin inflammatory disorders [19]. Melasma was associated with the increased ROS levels which will lead to the oxidation of proteins and lipids, and causing oxidative damage to the cells [20, 21, 22, 23]. Skin photoaging is also associated with ROS due to the exposure of the skin to sun light [24]. Recent studies also suggested melasma as a photoaging skin disorder [25]. Resveratrol is active in neutralizing, and inhibiting, the formation of ROS, but it also is effective in neutralizing synthetic DPPH and AAPH radicals in vitro [26]. Resveratrol was also proven to have radical scavenging properties owing most of it by the para/hydroxyl group of its structure [25, 27]. In a different study was observed to be a better antioxidant than many flavonoids [28]. For example, the antiradical activity of resveratrol relative to peroxide radicals was higher than catechins, gallic acid, and elagic acid (resveratrol> catechin> epicatechin = gallocatechin> gallic acid = ellagic acid.

In an in vitro study in human keratinocyte cells (HaCaT cells) after UV A radiation, considered by some authors as the major actor for the photoaging process [29], resveratrol is able to decrease oxidative by-products (e.g., maleic dialdehyde) and to increase antioxidants such as superoxide dismutase (SOD) and glutathione peroxidase (GPX) [30]. Manganese superoxide dismutase (MnSOD), a very important antioxidant enzyme, was also increased in the presence of resveratrol [31]. Compared to Vitamins A and C, it was proved to be even more effective against lipid peroxidation and protein oxidation in vitro [32, 33, 34], but also in an in vivo study in hairless mice [35]. Furthermore, DNA damage caused by peroxidyl radicals in human lymphocytes was reduced by resveratrol treatment after UV B induced H2O2 production [36]. Another key molecule in oxidation is the transcription factor nuclear factor-E2-related factor-2 (Nrf2) which regulates genes that help synthesize more antioxidants and remove ROS. Resveratrol upregulates Nrf2 which increase the levels of antioxidants such as GPX, SOD, catalase, and hemoxygenase [31, 37, 38]. In addition, Resveratrol activates a NAD+-dependent protein deacetylase, SIRT-1, a protein which is involved in cell survival against oxidative stress by decreasing the ROS levels [39]. In different in vivo studies was also observed an increase in SIRT-1 following resveratrol treatment of 0.02% in the diet for 4 weeks in wild-type mice Figure 3 [40].

Figure 3.

Association of Resveratrol in the different biological processes triggered by UV radiation in the skin.

2.1.2 Skin-whitening activity and photoaging protection

One the common clinical characteristic of melasma is the appearance of skin hyperpigmentation mainly in the face [22, 23]. In photoaging hyperpigmentation also occurs by cumulative sun exposure [41]. Resveratrol has the ability to modulate the tyrosinase activity by the inhibition of this enzyme and by acting as a competitive substrate, and thus blocking melanogenesis [42, 43, 44]. This compound also inhibits hyperpigmentation by other different mechanisms of action. According to Newton R. A. et al., 2007 [45], at a transcriptional level, resveratrol inhibits the mRNA expression of tyrosinase, tyrosinase-related proteins (Tyrp1 and Tyrp2), microphthalmia-associated transcription factor (MITF), a major regulator of melanogenesis, and DOPAchrome tautomerase (DCT) in human melanocytes in vitro study. On the other hand, it decreases the levels of melanin and in in vivo studies were observed by topically administration of resveratrol in guinea pig [46]. Resveratrol was also found effective in the inhibition of melanogenesis, Figure 3.

2.1.3 Anti-inflammatory activity and collagen synthesis stimulation

Both, in melasma and skin aging, a decrease in the quantity of collagen I, III, IV-VII (decrease in collagen I, IV in melasma, and all of them in skin aging) in the dermis and basal membrane has been described. In keratinocytes UV A radiation, ROS can upregulate the AP-1 (activator protein 1) and NF-kB (nuclear factor kappa beta) transcription factors [47, 48]. Their upregulation results in the induction of matrix metalloproteinase activity leading to the interference with intracellular signaling pathways responsible to the expression of genes regulating the process of collagen type I and III, resulting in hypertrophy and degradation of elastin and hyaluronic acid [45, 48, 50]. Resveratrol was found to reduce the expression of AP-1 and NF-kB transcription factors, limiting the degradation process of collagen and elastin in the skin, but also skin inflammation [48, 49, 51, 52]. In addition, resveratrol has been to act as an NF-kB inhibitor [53] which can be activated by ROS playing and important role in the inflammatory response [54, 55].

Advertisement

3. Wound healing potential of resveratrol

Another interesting potential property of this substance is their application to the wound healing process. Wound healing is a natural biological mechanism of repairing tissues after suffering from an injury. After tissue damage Nrf-2 and NF-kB play a crucial role in both inflammation and oxidation processes during wound healing process [56]. On the other hand, it is suggested that ROS in not excessive, low, levels are necessary for the wound healing process to fight against pathogens invading the organism, but not good when are produced in high levels in the tissue [57]. So, a control of the ROS produced by compounds such as Resveratrol knowing its proven anti-oxidant capacity is of interest to reduce the excess of tissue damage [58]. In addition, in a work from 2006 [59] was observed the association of an increase in the expression of the VEFG (Vascular Endotelian Growth Factor) in vitro and in vivo (mice) with the increase in agiogenesis which favored an improvement of the wound healing process. Evidence which demonstrates the potential of resveratrol on treating wound healing has been published [60, 61]. In this works was demonstrated the antioxidant, anti-inflammatory properties as well as the upregulation of Sirt-1 and VEFG expressions to play an important role in the ability of the resveratrol to improve wound healing in tissues such as the skin.

To sum up, if we take into account the related inhibition of the pro-inflammatory mediators’ expression, the ROS reduction ability, the scavenging properties, the increasing in angiogenesis via increasing VEFG and Sirtuins (Sirt-1), resveratrol seems to be a valuable candidate in order to both regulate and improve the wound healing process after skin damage.

Advertisement

4. Clinical evidence of resveratrol uses in cosmetics

The use of resveratrol in cosmetic formulas has increased in the last 15 years because of its potential biological activities described above. The use of this substance in cosmetic formulas such as a cream containing this active ingredient was studied in the work from Igielska-Kalwat [62]. In this study 20 volunteers were administrated topically on the face a cream composed by 0.007% resveratrol and with placebo (no resveratrol cream). Results after 6 weeks showed that treated patients increased skin hydration and firmness, concluding that resveratrol has moisturizing and tightening effects in skin but also safety without any sign of skin irritation. In a different work from Ferzli G. [63], a resveratrol enriched formulation which combined resveratrol with green tea polyphenols and caffeine, reduced facial redness in 13 of the 16 subjects from this study after 12 weeks study period. The other 3 subjects left were seen only to improve skin quality at the end of this study. In 2014, Farris P. [52] demonstrated also the efficacy of another resveratrol enhanced formulation (1% resveratrol, 0 1% Vitamin E and 0.5% baicalin) in the treatment of photodamaged skin. After a 12 weeks period an improvement in fine lines and wrinkles derived from photo aging processes were observed. In a similar work from 2013 [64] the efficacy on protecting the skin after UV aggression on 15 healthy volunteers was performed. In this study after repetitive UV radiation 1% resveratrol treatment after UV damage showed better protective effect even than other antioxidants alone, and logically better than placebo treated subjects.

In a different study form Moyano J.R. [65] a W/O (water in oil) cream was prepared to optimize the permeability and stability of the trans isomer of the resveratrol and study the elasticity, hydration and luminosity capacity of the formulas in 8 women ranging from 45 to 70 years old during a 30 days trial. Results suggested the efficacy of the resveratrol emulsion produced in all patients tested. The increase in all parameters studied was 20.53%, 49.70% and 6.17% for hydration, elasticity and colorimetry respectively.

Advertisement

5. Conclusions

As conclusion, resveratrol could be potentially effective in the treatment of several skin disorders, including diseases or signs of aging, for example. Several studies have shown important biological activity of resveratrol, especially in reconstituted skin models, skin cell cultures, or in animal models. The high activity, and efficacy, of resveratrol as both an antioxidant and a melanin synthesis inhibitor make this compound as a promising candidate for the treatment and prevention of skin aging. Despite this beneficial influence on the skin aging effects and dermal diseases, resveratrol is also effective in healing of wounds and burns. Exist similarities between melasma and skin aging (and photoaging) in terms of the hyperpigmentation, the basement membrane disruption of the skin, as well as the association with ROS owing to the UV exposure. These similarities would make resveratrol as a promising contributor for their treatment and prevention of melasma. Because the vast majority of the literature refers to the activity of resveratrol to in vitro studies and in vivo in animal models, it would be desirable more clinical evidences of its efficacy in human skin treatment.

In our opinion, resveratrol may be able to induce collagen synthesis in vivo, although the molecular mechanism is not clearly established. We pretend to proceed our study of this molecule, to give an added value to the potential opportunities of this compound.

Advertisement

Acknowledgments

The authors thanks to Dr. José Rocha from Mesosystem for the development of the pictures.

References

  1. 1. Fan E, Zhang K, Zhu M, Wang Q. Obtaining resveratrol: From chemical synthesis to biotechnological production. Mini-Reviews in Organic Chemistry. 2010;7(4):272-281
  2. 2. Ratz-Łyko A, Arct J. Resveratrol as an active ingredient for cosmetic and dermatological applications: A review. Journal of Cosmetic and Laser Therapy. 2018:1-7. DOI: 10.1080/14764172.2018.1469767
  3. 3. Bernard E, Britz-McKibbin P, Gernigon N. Resveratrol photoisomerization: An integrative guided-inquiry experiment. Journal of Chemical Education. 2007;84(7):1159-1161
  4. 4. Chen X, He H, Wang G, Yang B, Ren W, Ma L, et al. Stereospecific determination of cisand trans-resveratrol in rat plasma by HPLC: Application to pharmacokineticstudies. Biomedical Chromatography. 2007;21:257-265
  5. 5. Camont L, Cottart C-H, Rhayem Y, Nivet-Antoine V, Djelidi R, Collin F, et al. Simple spectrophotometric assessment of the trans−/cis-resveratrol ratio in aqueous solutions. Analytica Chimica Acta. 2009;634:121-128
  6. 6. Hecker A. The impact of resveratrol on skin wound healing, scarring, and aging. International Wound Journal. 2022;19(1):9-28
  7. 7. Walle T, Hsieh R, DeLegge MH, Oatis JE, Walle UK. High absorption but very low bioavailability of oral resveratrol in humans. Drug Metabolism and Disposition. 2004;32:1377-1382
  8. 8. Brown VA, Patel KR, Viskaduraki M, Crowell JA, Perloff M, Booth TD, et al. Repeat dose study of the cancer chemopreventive agent resveratrol in healthy volunteers: Safety, pharmacokinetics, and effect on the insulin-like growth factor axis. Cancer Research. 2010;70:9003-9011
  9. 9. Williams LD, Burdock GA, Edwards JA, Beck M, Bausch J. Safety studies conducted on high-purity trans-resveratrol in experimental animals. Food and Chemical Toxicology. 2009;47:2170-2182
  10. 10. Cottart CH, Nivet-Antoine V, Laguillier-Morizot C, Beaudeux JL. Resveratrol bioavailability and toxicity in humans. Molecular Nutrition & Food Research. 2010;54(1):7-16
  11. 11. Amri A, Chaumeil JC, Sfar S, Charrueau CJ. Administration of resveratrol: What formulation solutions to bioavailability limitations? Journal of Controlled Release. 2012;158:182-193
  12. 12. Hung CF, Lin YK, Huang ZR, Fang JY. Delivery of resveratrol, a red wine polyphenol, from solutions and hydrogels via the skin. Biological & Pharmaceutical Bulletin. 2008;31:955-962
  13. 13. Timmers S, Auwerx J, Schrauwen P. The journey of resveratrol from yeast to human. Aging (Albany NY). 2005;4:146-158
  14. 14. Abla MJ, Banga AK. Quantification of skin penetration of antioxidants of varying lipophilicity. International Journal of Cosmetic Science. 2013;35(1):19-26
  15. 15. Borek C. Molecular mechanisms in cancer induction and prevention. Environmental Health Perspectives. 1993;101(3):237-245
  16. 16. Kuse Y, Ogawa K, Tsuruma K, Shimazawa M, Hara H. Damage of photoreceptor-derived cells in culture induced by light emitting diode-derived blue light. Scientific Reports. 2014;4:5223, 1-12
  17. 17. Liebel F, Kaur S, Ruvolo E, Kollias N, Southall MD. Irradiation of skin with visible light induces reactive oxygen species and matrix-degrading enzymes. The Journal of Investigative Dermatology. 2012;132(7):1901-1907
  18. 18. Lohan SB et al. Free radicals induced by sunlight in different spectral regions – In vivo versus ex vivo study. Experimental Dermatogology. 2016;25:380-385
  19. 19. Cai H, Xie Z, Liu G, Sun X, Peng G, Lin B, et al. Isolation, identification and activities of natural antioxidants from callicarpa kwangtungensis chun. PLoS One. 2004;9:e93000
  20. 20. Handel AC, Handel AC, Miot LD, Miot HA. Melasma: A clinical and epidemiological review. Anais Brasileiros de Dermatologia. 2014;89(5):771-782
  21. 21. Passeron T. Melasma pathogenesis and influencing factors – An overview of the latest research. JEADV. 2013;27(1):5-6
  22. 22. Lee A-Y. An updated review of melasma pathogenesis. Dermatologica sinica. 2014;32(4):233-239
  23. 23. Ogbechie-Godec OA, Elbuluk N. Melasma: An up-to-date comprehensive review. Dermatology and Therapy. 2017;7(3):305-318
  24. 24. Ichihashi M, Ando H, Yoshida M, Niki Y, Matsui M. Photoaging of the skin. Anti-Aging Medicine. 2009;6(6):46-59
  25. 25. Passeron T, Picardo M. Melasma, a photoaging disorder. Pigment Cell & Melanoma Research. 2018;31(4):461-465
  26. 26. Miura T, Muraoka S, Ikeda N, Watanabe M, Fujimoto Y. Antioxidative and prooxidative action of stilbene derivatives. Pharmacology & Toxicology. 2000;86:203-208
  27. 27. Stojanović S, Sprinz H, Brede O. Efficiency and mechanism of the antioxidant action of trans-resveratrol and its analogues in the radical liposome oxidation. Archives of Biochemistry and Biophysics. 2001;391:79-89
  28. 28. Yilmaz Y, Toledo RT. Major flavonoids in grape seeds and skins. Antioxidant capacity of catechin, epicatechin, and gallic acid. Journal of Agricultural and Food Chemistry. 2004;52:255-260
  29. 29. Nouveau S, Agrawal D, Kohli M, Bernerd F, Misra N, Nayak CS. Skin Hyperpigmentation in Indian population: Insights and best practice. Indian Journal of Dermatology. 2016;61(5):487-495
  30. 30. Chen ML, Li J, Xiao WR, et al. Protective effect of resveratrol against oxidative damage of UVA irradiated HaCaT cells. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2006;31(5):635-639
  31. 31. Carrizzo A, Puca A, Damato A, Marino M, Franco E, Pompeo F, et al. Resveratrol improves vascular function in patients with hypertension and dyslipidemia by modulating NO metabolism. Hypertension. 2013;62:359
  32. 32. Weber SU, Thiele JJ, Cross CE, Packer L. Vitamin C, uric acid, and glutathione gradients in murine stratum corneum and their susceptibility to ozone exposure. The Journal of Investigative Dermatology. 1999;113(6):1128-1132
  33. 33. Baxter RA. Anti-aging properties of resveratrol: Review and report of a potent new antioxidant skin care formulation. Journal of Cosmetic Dermatology. 2008;7:2
  34. 34. Fang JG, Lu M, Chen ZH, et al. Antioxidant effects of resveratrol and its analogues against the freeradical-induced peroxidation of linoleic acid in micelles. Chemistry. 2002;8(18):4191-4198
  35. 35. Afaq F, Adhami VM, Ahmad N. Prevention of short-term ultraviolet B radiation-mediated damages by resveratrol in SKH-1 hairless mice. Toxicology and Applied Pharmacology. 2003;186:28-37
  36. 36. Yen GC, Duh PD, Lin CW. Effects of resveratrol and 4-hexylresorcinol on hydrogen peroxide-induced oxidative DNA damage in human lymphocytes. Free Radical Research. 2003;37(5):509-514
  37. 37. Ungvari Z, Orosz Z, Rivera A, et al. Resveratrol increases vascular oxidative stress resistance. American Journal of Physiology. Heart and Circulatory Physiology. 2007;292(5):12
  38. 38. Harikumar KB, Aggarwal BB. Resveratrol: A multitargeted agent for age-associated chronic diseases. Cell Cycle. 2008;7(8):1020-1035
  39. 39. Kwon S-H et al. Depigmenting effect of resveratrol is dependent on FOXO3a activation without SIRT1 activation. International Journal of Molecular Sciences. 2017;18:1213
  40. 40. Nakata R, Takahashi S, Inoue H. Recent advances in the study on resveratrol. Biological & Pharmaceutical Bulletin. 2012;35:273
  41. 41. Flament F, Bazin R, Laquieze S, Rubert V, Simonpietri E, Piot B. Effect of the sun on visible clinical signs of aging in Caucasian skin. Clinical, Cosmetic and Investigational Dermatology. 2013;6:221-232
  42. 42. Lee SY, Baek N, Nam T-g. Natural, semisynthetic and synthetic tyrosinase inhibitors. Journal of Enzyme Inhibition and Medicinal Chemistry. 2016;31(1):1-13
  43. 43. Chang T-S. An updated review of tyrosinase inhibitors. International Journal of Molecular Sciences. 2009;10:2440-2475
  44. 44. Loizzo MR, Tundis R, Menichini F. Natural and synthetic tyrosinase inhibitors as antibrowning agents: An update. Comprehensive Reviews in Food Science and Food Safety. 2012;11:378-398
  45. 45. Newton RA, Cook AL, Roberts DW, Leonard JH, Sturm RA. Posttranscriptional regulation of melanin biosynthetic enzymes by cAMP and resveratrol in human melanocytes. The Journal of Investigative Dermatology. 2007;127:2216-2227
  46. 46. Lee TH, Seo JO, Baek SH, Kim SY. Inhibitory effects of resveratrol on melanin synthesis in ultraviolet B-induced pigmentation in guinea pig skin. Biomolecules & Therapeutics (Seoul). 2014;22:35-40
  47. 47. Adhami VM, Afaq F, Ahmad N. Suppression of ultraviolet B exposure-mediated activation of NF-kappaB in normal human keratinocytes by resveratrol. Neoplasia. 2003;5(1):74-82
  48. 48. Kundu JK, Shin YK, Surh YJ. Resveratrol modulates phorbol ester-induced pro-inflammatory signal transduction pathways in mouse skin in vivo: NF-kappaB and AP-1 as prime targets. Biochemical Pharmacology. 2006;72(11):1506-1515
  49. 49. Sen CK, Khanna S, Gordillo G, Bagchi D, Bagchi M, Roy S. Oxygen, oxidants, and antioxidants in wound healing: An emerging paradigm. Annals of the New York Academy of Sciences. 2002;957:239-249
  50. 50. Petrat F, de Groot H. Protection against severe intestinal ischemia/reperfusion injury in rats by intravenous resveratrol. The Journal of Surgical Research. 2011;167(2):29
  51. 51. Leighton F, Cuevas A, Guasch V, Perez DD, Strobel P, San MA, et al. Plasma polyphenols and antioxidants, oxidative DNA damage and endothelial function in a diet and wine intervention study in humans. Drugs under Experimental and Clinical Research. 1999;25:133
  52. 52. Farris P, Krutmann J, Li Y-H, McDaniel D, Krolj Y. Resveratrol: A unique antioxidant offering a multi-mechanistic approach for treating aging skin. Journal of Drugs in Dermatology. 2013;12:1389
  53. 53. Nam N-H. Naturally occurring NF-Kb inhibitors. Mini-Reviews in Medicinal Chemistry. 2006;6:945-951
  54. 54. Lawrence T. The nuclear factor NF-kappaB pathway in inflammation. Cold Spring Harbor Perspectives in Biology. 2009;1(6):a001651
  55. 55. Wang T, Zhang X, Jian LJ. The nuclear factor NF-kappaB pathway in inflammation. International Immunopharmacology. 2002;2(11):1509-1520
  56. 56. Ambrozova N, Ulrichova J, Galandakova A. Models for the study of skin wound healing. The role of Nrf2 and NF-κB. Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czech Republic. 2017;161(1):1-13
  57. 57. Cano SM, Lancel S, Boulanger E, Neviere R. Targeting oxidative stress and mitochondrial dysfunction in the treatment of impaired wound healing: A systematic review. Antioxidants. 2018;7(8):98
  58. 58. Bilgen F, Ural A, Kurutas EB, Bekerecioglu M. The excess of oxidative stress and Raftlin levels on woundn healing. International Wound Journal. 2019;16(5):1178-1184
  59. 59. Kanno Y et al. Lack ofa2-antiplasmin improves cutaneous wound healing viaover-released vascular endothelial growth factor-inducedangiogenesis in wound lesions. Journal of Thrombosis and Haemostasis. 2006;4(7):1602-1610
  60. 60. Zhou X, Ruan Q , Ye Z, Chu Z, et al. Resveratrol accelerates wound healing by attenuating oxidative stress-induced impairment of cell proliferation and migration. Burns. 2021;47(1):133-139
  61. 61. Farris P, Yatskayer M, Chen N, Krol Y, Oresajo C. Evaluation of efficacy and tolerance of a nighttime topical antioxidant containing resveratrol, baicalin, and vitamin e for treatment of mild to moderately photodamaged skin. Journal of Drugs in Dermatology. 2014;13(12):1467-1472
  62. 62. Igielska-Kalwat J, Firlej F, Lewandowska A, Biedziak B. In vivo studies of resveratrol contained in cosmetic emulsions. Acta Biochimica Polonica. 2019;66(3):371-374
  63. 63. Ferzli G, Patel M, Phrsai N, Brody N. Reduction of facial redness with resveratrol added to topical product containing green tea polyphenols and caffeine. Journal of Drugs in Dermatology. 2013;12:770-774
  64. 64. Wu Y, Jia LL, Zheng YN, Xu XG, Luo YJ, Wang B, et al. Resveratrate protects human skin from damage due to repetitive ultraviolet irradiation. Journal of the European Academy of Dermatology and Venereology. 2013;27:345-350
  65. 65. Moyano JR, Fabbrocini G, de Stefano D, Mazzella C. Enhanced antioxidant effect of trans-resveratrol: Potential of binary systems with polyethylene glycol and cyclodextrin. Drug Development and Industrial Pharmacy. 2013;40(10):1-8

Written By

Javier Fidalgo, Ana Novo Barros and Ana Casas

Submitted: 02 August 2022 Reviewed: 05 September 2022 Published: 13 October 2022